Genome Editing in Engineered T Cells for Cancer Immunotherapy

Advanced gene transfer technologies and profound immunological insights have enabled substantial increases in the efficacy of anticancer adoptive cellular therapy (ACT). In recent years, the U.S. Food and Drug Administration and European Medicines Agency have approved six engineered T cell therapeut...

Celý popis

Podrobná bibliografia

Vydané v:	Human gene therapy Ročník 34; číslo 17-18; s. 853
Hlavní autori:	Bonini, Chiara, Chapuis, Aude G, Hudecek, Michael, Guedan, Sonia, Magnani, Chiara, Qasim, Waseem
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.09.2023
Predmet:	Anniversaries and Special Events B-Lymphocytes Gene Editing Humans Immunotherapy Neoplasms - genetics Neoplasms - therapy T-Lymphocytes United States United States CRISPR CAR TCR
ISSN:	1557-7422, 1557-7422
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!